[Effect of acetylcysteine by oral administration in bronchopneumophthiseology. Double blind controlled test concerning its effects on stagnation patterns of bronchial secretions].
D000081:Acetamides / Q000627:therapeutic use; D000111:Acetylcysteine / Q000008:administration & dosage* / Q000627:therapeutic use; D000284:Administration, Oral; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001980:Bronchi / Q000378:metabolism*; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D006801:Humans; D010627:Phenethylamines / Q000627:therapeutic use; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D013450:Sulfones / Q000627:therapeutic use; D014783:Viscosity
D000081:Acetamides; D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D010627:Phenethylamines; D013450:Sulfones; D000111:Acetylcysteine
Sull'attivitá dell'acetilcisteina per via orale in broncopneumotisilogia. Ricerca controllata doppio-cieca relativa agli effetti sui quardi da ristagno dei secreti bronchiali.